Expanding Biolab Complex in Berkeley Has Residents Worried
By Sharon Lerner, Lee Fang,
The Intercept [cites CGS' Marcy Darnovsky]
| 06. 09. 2021
The Bayer Corporation has made it clear that the creation of a biological research facility on its waterfront property in Berkeley, California, will not have any significant impact on birds, air quality, greenhouse gas emissions, traffic, or noise levels. But while the company’s application to the Berkeley City Council to extend the 30-year development plan for its 46-acre campus is filled with meticulous details, down to the vibration levels of the various pieces of construction equipment that may build it and the degree to which sunlight will reflect off the new buildings, the company has provided area residents with far less clarity on the research that will go on inside its newly expanded complex and how it might affect them.
“What are they going to do there? What kind of microorganisms are they going to be working with?” asked Marcy Darnovsky. “They say they’re going to follow all the rules. Well, is there any oversight?” Darnovsky, a resident of the area and executive director of the Center for Genetics and Society, which advocates for the responsible use of biotechnology, is asking questions that have...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...